Free Trial

Thomas Stephan Analyst Performance

Analyst at Stifel Nicolaus

Thomas Stephan is a stock analyst at Stifel Nicolaus in the medical sector, covering 6 publicly traded companies. Over the past year, Thomas Stephan has issued 10 stock ratings, including buy and hold recommendations. While full access to Thomas Stephan's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Thomas Stephan's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
10 Last 0 Years
Buy Recommendations
40.00% 4 Buy Ratings
Companies Covered
6 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy40.0%4 ratings
Hold60.0%6 ratings
Sell0.0%0 ratings

Out of 10 total stock ratings issued by Thomas Stephan at Stifel Nicolaus, the majority (60.0%) have been Hold recommendations, followed by 40.0% Buy.

Best & Worst Calls

This analyst does not have any ratings with enough history to determine best and worst calls.

Exchange Coverage

ExchangePercentageCount
NASDAQ
66.7% of companies on NASDAQ
4 companies
NYSE
33.3% of companies on NYSE
2 companies

Thomas Stephan, an analyst at Stifel Nicolaus, currently covers 6 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
6 companies
100.0%

Thomas Stephan of Stifel Nicolaus specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MED INSTRUMENTS
4 companies
66.7%
MED/DENTAL - SUPP
1 company
16.7%
MEDICAL SERVICES
1 company
16.7%

Thomas Stephan's Ratings History at Stifel Nicolaus

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
TransMedics Group, Inc. stock logo
TMDX
TransMedics Group
9/4/2025Initiated Coverage$106.94$115.00Hold
STAAR Surgical Company stock logo
STAA
STAAR Surgical
8/7/2025Set Price Target$26.90$28.00Hold
Glaukos Corporation stock logo
GKOS
Glaukos
5/1/2025Lower Price Target$80.03$115.00Buy
RxSight, Inc. stock logo
RXST
RxSight
3/19/2025Lower Price Target$25.73$28.00Hold
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
3/6/2025Lower Price Target$2.30$4.00Buy
RxSight, Inc. stock logo
RXST
RxSight
2/26/2025Lower Price Target$27.30$33.00Hold
STAAR Surgical Company stock logo
STAA
STAAR Surgical
2/12/2025Lower Price Target$15.77$20.00Buy
Sight Sciences, Inc. stock logo
SGHT
Sight Sciences
2/6/2025Lower Price Target$2.80$5.00Buy
Bausch + Lomb Corporation stock logo
BLCO
Bausch + Lomb
1/29/2025Lower Price Target$17.41$18.00Hold
RxSight, Inc. stock logo
RXST
RxSight
1/13/2025Lower Price Target$28.10$35.00Hold